No Time to Lose: Solutions to Increase COVID-19 Vaccinations in the States
The House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations will hold a hearing on COVID-19 vaccine distribution and administration.
Find more details here.
Wednesday, February 3
Road to Recovery – Ramping Up COVID-19 Vaccines, Testing, and Medical Supply Chain
The House Committee on Energy and Commerce, Subcommittee on Health will hold a hearing on the federal government’s handling of COVID-19 vaccine development, testing and the medical supply chain.
Find more details here.
Congress
Rep. Underwood Reintroduces Bill Enhancing ACA Credits
On Jan. 19, Rep. Lauren Underwood (D-IL) reintroduced legislation to expand and enhance the Affordable Care Act’s (ACA) tax credits, also included in President Biden’s health reform agenda. The Health Care Affordability Act of 2021 would increase the generosity of the existing tax credits for consumers earning up to 400 percent of
Featured Post, healthcare January 26, 2021 at 5:40 pm
In February of last year, Michigan Governor Gretchen Whitmer convened a task force to study the causes of increasing prescription drug costs and to make recommendations to solve this intractable problem. Today, the task force released its report and it has a number of steps the state government can take help get control over drug prices which are rising much faster than the rate of inflation. It outlines key policy solutions and offers recommendations on four key areas: Transparency, Affordability, Accountability, and Accessibility.
The report goes into detail about the complex interplay of multiple stakeholders in the prescription drug market, shown here graphically:
Bollyky & Kesselheim on U.S. Prescription Drug Importation
Thomas J. Bollyky (Council on Foreign Relations) & Aaron S. Kesselheim (Brigham and Women s Hospital/Harvard Medical School) have posted Reputation and Authority: The FDA and the Fight over U.S. Prescription Drug Importation (Vanderbilt Law Review, Vol. 73, No. 5, 1331) on SSRN. Here is the abstract:
There is popular and bipartisan support for legalizing the importation of lower-cost medicines from Canada to help reduce the high prescription drug costs that Americans pay. Despite the wide interest in this policy, attempts over the last sixteen years to create a formal system for large-scale prescription drug importation in the United States have failed. The Trump Administration recently issued a final rule to enable the legal importation of prescription drugs from Canada, but the rule has important design flaws and seems destined to suffer a similar fate as previous efforts.
they murder people with machetes. they sell children into prostitution, and they deal drugs in poorut communities. in what sense are they being demonized ? what is the upside of ms-13? i m not saying there is an upside. what i am saying is the attorney general should be more accurate in what he accuses them of. he accuses them of being in a cartel and they weren t doing that. he accused them of he tucker: it s not my job to defend the attorney general s description but a cartel doesn t just refer to people, to drug distribution. drug importation. it can be any group of people who are coming together for an illegal purpose or have a monopoly in the area. i think that is a definition. that s not the way it is generally used. that was my issue with him. i think why they are front and center in being called america s public enemy number one, which when you have that title, you will call a lot of attention to this group from all over. the reason they have been named that is because